The combination of NT-proBNP, cardiac troponins, galectin-3, sST-2, GDF-15, and suPAR represents a promising approach for a more comprehensive cardiovascular risk assessment and mortality prediction in CKD patients. The gene discussed is GDF15; the disease is chronic kidney disease.